A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in Vitro and in Vivo

Journal of Infectious Diseases

Volumn 194, Issue 5, 2006, Pages 584-587

  Haque, Tanzina ^a,d   Johannessen, Ingolfur ^a   Dombagoda, Dilani ^a   Sengupta, Chandrya ^b   Burns, David M ^a   Bird, Pru ^c   Hale, Geoff ^c   Mieli Vergani, Giorgina ^b   Crawford, Dorothy H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 350; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 72A1; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOSIS; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERSENSITIVITY REACTION; HYPOTENSION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL CYANOSIS; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SCID MOUSE; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TUMOR; VIRUS INFECTION; VOMITING;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; BURKITT LYMPHOMA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, SCID; TRANSPLANTATION IMMUNOLOGY;

EID: 33748079141     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505912     Document Type: Article

References (15)

1. Haque T, Thomas JA, Falk K, et al. Transmission of donor Epstein-Barr virus in transplanted organ causes lymphoproliferative diseases in recipient. J Gen Virol 1996; 77:1169-72.
2. Hoffman GJ, Lazarowitz SG, Hayward DH. Monoclonal antibody against a 250,000-Dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc Natl Acad Sci USA 1980; 77:2979-83.
3. Thorley-Lawson DA, Geilinger K. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci USA 1980; 77:5307-11.
4. Miller G, Heston L, Hoffman G. Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody. Infect Immun 1982;37:1028-31.
5. Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Nguyen QV, Humphreys RE. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J Virol 1988; 62:2614-21.
6. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256-9.
7. Johannessen I, Crawford DH. In vivo models for Epstein-Barr virus-associated B cell lymphoproliferative disease. Rev Med Virol 1999; 9:263-77.
8. Wison AD, Morgan AJ. Indirect measurements of Epstein-Barr virus neutralizing antibodies by ELISA. J Virol Methods 1998; 73:11-9.
9. Cannon MJ, Pisa P, Fox RI, Cooper NR. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in scid/hu chimeric mice. J Clin Invest 1990; 85:1333-7.
10. Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11:499-520.
11. Howe JG, Steitz JA. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 1986; 83:9006-10.
12. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 1966; 91:1248-56.
13. Epstein MA, Morgan AJ, Finerty S, Randle BJ, Kirkwood JK. Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 1985; 318:287-9.
14. Abedi MR, Linde A, Christensson B, Mackett M, Hammarstrom L, Smith CI. Preventive effect of IgG from EBV-seropositive donors on the development of human lymphoproliferative disease in SCID mice. Int J Cancer 1997; 71:624-9.
15. Breedveld FC. Therapeutic monoclonal antibodies. Lancet 2000; 355:735-40.